BioCentury
ARTICLE | Financial News

Apricus proposes follow-on

March 31, 2017 7:34 PM UTC

Urology and rheumatology company Apricus Biosciences Inc. (NASDAQ:APRI) proposed to raise up to $6.9 million in a follow-on underwritten by H.C. Wainwright on March 30....

BCIQ Company Profiles

Apricus Biosciences Inc.